Skip to content

POTS Adrenergic Ab (CIHR Aims #1&2)

Postural Tachycardia Syndrome

Objective: In this pilot study, we will test the hypothesis that patients with POTS (age 18-60 years) will have a higher percentage of functional antibodies to adrenergic receptors compared with control subjects without POTS.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    18 to 60

Participation Criteria

Inclusion Criteria:

* Patients who have been previously diagnosed with POTS
* Control subjects (patients not diagnosed with POTS)
* Age between 18 - 60 years
* Males and Females (Give that \>80% of POTS patients are female, we will attempt to enroll a similar percentage of female control subjects)
* Able and willing to provide consent

Exclusion Criteria:

* Smokers
* Overt cause for postural tachycardia, i.e., acute dehydration
* Significant cardiovascular, pulmonary, hepatic, or hematological disease by history or prior testing
* Highly trained athletes
* Subjects with somatization or severe anxiety symptoms will be excluded
* Use of drospirenone (a spironolactone analogue) containing oral contraceptive agent
* Hypertension defined as supine resting BP\>145/95 mmHg off medications or needing antihypertensive medication
* Other factors which in the investigator's opinion would prevent the participant from completing the protocol, including poor compliance during previous studies or an unpredictable schedule
* Unable to give informed consent

Study Location

University of Calgary
University of Calgary
Calgary, Alberta
Canada

Contact Study Team

Backup Contact

Robert S Sheldon, MD, PhD

[email protected]
403-220-8191
Primary Contact

Satish R Raj, MD, MSCI

[email protected]
403-210-6152
Study Sponsored By
University of Calgary
Participants Required
More Information
Study ID: NCT02673996